Trendy blogs

  The global   dental market   was valued at USD 37.86 billion in 2024 and is expected to expand from USD 41.03 billion in 2025 to USD 87.65 billion by 2032, reflecting a compound annual growth rate (CAGR) of 11.5% during the forecast period. In 2024, North America led the market, holding a dominant share of 39.06%. Request a Free Sample PDF Brochure of Dental Market :  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/106251 In its latest study, Fortune Business Insights offers an in-depth analysis of the global Dental Market for the forecast period of 2025–2032. The report highlights key drivers, challenges, opportunities, and market trends. Additionally, the report provides market share insights expressed in both value and volume for the various segments. Key Industry Development January 2024:  Dentsply Sirona entered into a four-year partnership with the International Association for Disability & Oral Health (iADH) to increase oral care ...

 The global Contract Research Organization (CRO) services market was valued at USD 79.54 billion in 2023. It is expected to expand from USD 86.33 billion in 2024 to USD 175.46 billion by 2032, reflecting a compound annual growth rate (CAGR) of 9.3% over the forecast period. In 2023, North America led the global CRO services market, holding a dominant market share of 50.41%. Request a Free Sample PDF Brochure of CRO Services Market :  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100864 In its latest study, Fortune Business Insights offers an in-depth analysis of the global CRO Services Market for the forecast period of 2024–2032. The report highlights key drivers, challenges, opportunities, and market trends. Additionally, the report provides market share insights expressed in both value and volume for the various segments. Top Companies in the Market Medpace (U.S.) Laboratory Corporation of America Holdings (U.S.) ICON plc (Ireland) IQVIA Inc (U.S.) Syneo...

  The global   hemorrhoid treatment market   was valued at USD 1.03 billion in 2023 and is expected to expand from USD 1.08 billion in 2024 to USD 1.74 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.1% throughout the forecast period. Hemorrhoids are a common condition characterized by swollen and inflamed veins in the rectum and anus, leading to discomfort and bleeding. This condition affects millions of people globally and can result from various factors, including straining during bowel movements, prolonged sitting, obesity, pregnancy, and chronic constipation. Request a Free Sample PDF Brochure :  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hemorrhoid-treatment-market-110985   Key Industry Development In September 2024, Haleon Group of Companies agreed to acquire Tianjin TSKF Pharmaceutical Co. Ltd., China. This acquisition aimed to deliver greater control and increased strategic and operational flexibility across...

  The global   dental handpiece market  was valued at USD 0.93 billion in 2024 and is expected to expand from USD 0.97 billion in 2025 to USD 1.33 billion by 2032, reflecting a compound annual growth rate (CAGR) of 4.6% over the forecast period. In 2024, North America held the largest market share, accounting for 40.86% of the global dental handpiece market. In its latest study, Fortune Business Insights offers an in-depth analysis of the global dental handpiece market for the forecast period of 2025–2032. The report highlights key drivers, challenges, opportunities, and market trends. Additionally, the report provides market share insights expressed in both value and volume for the various segments. Request a Free Sample PDF Brochure   https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dental-handpiece-market-109985   Top Companies in the Market KaVo Dental (Germany) Dentsply Sirona (U.S.) Nakanishi Inc. (Japan) TEALTH FOSHAN MEDICAL EQUIPMENT C...

  The global   preclinical CRO market  was valued at USD 6.84 billion in 2022 and is expected to expand from USD 7.79 billion in 2023 to USD 19.41 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.9% during the forecast period (2023-2030). North America led the market, contributing a value of USD 3.42 billion in 2022.   Request a Free Sample PDF Brochure of Preclinical CRO Market :  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/106939 Top Companies in the Market The preclinical CRO market is highly competitive, with several key players dominating the landscape. These companies offer a wide range of services, including toxicology testing, bioanalysis, pharmacokinetics, and safety assessment. Leading companies in the market include: Novotech (Australia) Thermo Fisher Scientific Inc. (U.S.) Medpace (U.S.) Icon plc (Ireland) Syneos Health (U.S.) Laboratory Corporation of America (U.S.) Eurofins Discovery (U.S.) EVOTEC (Germa...

  The global   rehabilitation robots market   was valued at USD 529.8 million in 2018 and is expected to surge to USD 8,966.7 million by 2032, reflecting a robust CAGR of 22.4% throughout the forecast period (2018-2032). In 2018, North America led the market, accounting for a dominant share of 74.76%. The rehabilitation robots market is experiencing significant growth, driven by technological advancements and an increasing demand for effective rehabilitation solutions. These robots are revolutionizing the way patients recover from injuries, neurological conditions, and mobility impairments. By providing targeted therapy, rehabilitation robots are improving patient outcomes and reducing the burden on healthcare professionals. Request a Free Sample PDF Brochure of Rehabilitation Robots Market :  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/101013 Key Industry Development One of the major breakthroughs in the rehabilitation robotics industry o...

  The global   diabetes drugs market  was valued at   USD 88.32 billion in 2024   and is expected to expand significantly. Projections indicate that the market will grow from   USD 101.48 billion in 2025   to   USD 233.84 billion by 2032 , demonstrating a   compound annual growth rate (CAGR) of 12.7%   during the forecast period. Request a Free Sample PDF Brochure of Diabetes Drugs Market :  https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100570 In its latest study, Fortune Business Insights offers an in-depth analysis of the global Diabetes Drugs Market for the forecast period of 2025–2032. The report highlights key drivers, challenges, opportunities, and market trends. Additionally, the report provides market share insights expressed in both value and volume for the various segments. Top Companies in the Market Novo Nordisk A/S (Denmark) Sanofi (France) Merck & Co., Inc. (U.S.) Eli Lilly and Company (U.S.) A...